Cancer Gene Therapy Research Yields New Insights into Glioblastoma Treatment

Strategic Insights -

Researchers at Medical University of Warsaw have made significant progress in understanding cancer gene therapy, particularly in the treatment of glioblastoma, the most aggressive and common type of primary brain cancer. Current treatments result in only a 12- to 15-month mean overall survival, emphasizing the urgent need for more effective treatments. The researchers reviewed existing challenges and prospective solutions, highlighting emerging advancements in gene therapy, immunotherapy, and anti-angiogenic drugs.

Key Takeaways:

  • The standard treatment for glioblastoma consists of surgery, radiotherapy, and chemotherapy, resulting in a mean overall survival of around 12 to 15 months.
  • Emerging strategies for glioblastoma treatment include gene therapy, immunotherapy, viral (oncolytic) therapies, and anti-angiogenic drugs.
  • Convection-enhanced delivery (CED) is being explored as a method to overcome the brain blood barrier and improve the delivery of therapeutic agents.
  • Promising therapies include dendritic vaccines (DCVax-L), CAR-T therapies targeted against IL13Ra2 and EGFRvIII, and oncolytic viruses: G47D (DELYTACT) and PVSRIPO.
  • The increasing focus is on combining multimodal therapies to achieve prolonged progression-free survival and overall survival.

Statistics:

  • Mean overall survival for glioblastoma patients undergoing standard treatment is around 12-15 months (1).
  • Current research aims to achieve prolonged progression-free survival and overall survival (1).
  • Convection-enhanced delivery (CED) holds promise for improving the delivery of therapeutic agents (1).
  • The new therapies being explored have shown promising results in clinical trials (1).

Sources:

  • (1) Current and prospective strategies in the management of Glioblastoma. Journal of Education, Health and Sport, 2025,Vol. 82.
  • (2) NewsRx. Studies from Medical University of Warsaw Have Provided New Data on Cancer Gene Therapy (Current and prospective strategies in the management of Glioblastoma). Vaccine Weekly. June 25, 2025; p 50.